Clinical Trials for Anixa Biosciences

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Anixa Biosciences

Clinical Trials (2)

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

PHASE1Recruiting

10 participants

Started: Apr 28, 2022 · Completed: May 31, 2029

1 condition2 sponsors1 location

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

EARLY_PHASE1Active, not recruiting

35 participants

Started: Oct 1, 2021 · Completed: May 31, 2026

3 conditions3 sponsors1 location